A. Overview of Vietnam\u2019s Healthcare Sector
\nVietnam has firmly established itself as one of the most attractive investment destinations in Southeast Asia. Nowhere is this more evident than in the healthcare and life sciences sector, which is undergoing a structural transformation driven by demographics, economic growth, and policy reform.
\nA rapidly aging population, a growing and increasingly health-conscious middle class, and the continued inflow of expatriates and skilled foreign workers are significantly increasing demand for high-quality, accessible, and internationally benchmarked healthcare services.
\nAt the same time, Vietnam is transitioning from a volume-based healthcare system to a quality-driven model. This shift creates substantial opportunities across the entire value chain:
\n\u2022\thealthcare service providers,
\n\u2022\tpharmaceutical and medical device manufacturers,
\n\u2022\tclinical research organizations,
\n\u2022\tdigital health and telemedicine platforms.
\nThe sector is also increasingly seen as a strategic pillar of economic development. Investments in healthcare do not only improve patient outcomes\u2014they stimulate domestic innovation, strengthen SMEs, and attract long-term foreign direct investment (FDI) and public-private partnerships (PPP).
\nA critical success factor will be effective cooperation between public authorities and private investors. Vietnam\u2019s long-term ambition is clear:
\n\u2022\tensure equitable and timely access to care,
\n\u2022\tsignificantly upgrade treatment quality, and
\n\u2022\treduce outbound medical tourism by building trusted domestic alternatives.
\nFor investors, the key message is equally clear: Vietnam is no longer an emerging market opportunity alone\u2014it is becoming a structured, policy-driven healthcare growth story.
\nB. Outpatient Transformation: Home Care and Decentralized Treatment
\nOne of the most pressing structural challenges in Vietnam\u2019s healthcare system remains hospital overcrowding, particularly at central and provincial levels.
\nDespite continuous investment in infrastructure, demand for inpatient services still exceeds capacity. As a result, Vietnam is increasingly shifting toward a more decentralized, outpatient-oriented model of care.
\nHome care and home-based treatment are emerging as critical components of this transformation.
\nCurrently:
\n\u2022\tmany hospitals have introduced post-discharge home monitoring services,
\n\u2022\tbut professional home care infrastructure remains underdeveloped,
\n\u2022\tand families still carry a significant share of the care burden.
\nThis creates both a social challenge and a commercial opportunity.
\nPatients often face substantial indirect costs:
\n\u2022\ttravel,
\n\u2022\taccommodation during treatment,
\n\u2022\tincome loss.
\nThese factors can be as burdensome as medical expenses themselves.
\nWithout proper follow-up care, patients frequently experience complications, leading to re-hospitalization and higher system costs.
\nProfessional homecare solutions\u2014supported by digital health tools, remote monitoring, and trained personnel\u2014offer a scalable solution:
\n\u2022\treducing pressure on hospitals,
\n\u2022\timproving patient outcomes,
\n\u2022\tlowering overall healthcare expenditure.
\nFor investors, this segment is particularly attractive due to:
\n\u2022\tlow initial infrastructure requirements,
\n\u2022\tstrong alignment with government policy,
\n\u2022\tand high unmet demand, especially for chronic disease management.
\nC. Implementation: Legal and Regulatory Priorities
\nFor Vietnam to fully unlock its healthcare investment potential\u2014especially in innovative areas such as homecare, digital health, and advanced medical technologies\u2014two regulatory priorities are essential:
\n1. Transparent and Investor-Friendly Legal Framework
\nVietnam has made significant progress in recent years. However, investors still require:
\n\u2022\tclear licensing pathways,
\n\u2022\tpredictable approval timelines,
\n\u2022\tand consistent interpretation of regulations across provinces.
\nA transparent framework will:
\n\u2022\tencourage technology transfer,
\n\u2022\treduce entry barriers,
\n\u2022\tand enhance confidence among multinational healthcare players.
\n2. Streamlined Administrative Procedures
\nAdministrative efficiency remains a decisive factor.
\nAccelerating:
\n\u2022\tproduct registration (especially for medical devices),
\n\u2022\tclinical trial approvals,
\n\u2022\tand market access procedures
\nwill be critical to ensuring that innovative healthcare solutions reach patients faster.
\nEncouragingly, recent reforms\u2014particularly in digitalization of administrative processes\u2014indicate that Vietnam is moving in the right direction.
\nD. Medical Devices Industry: Compliance and Code of Conduct
\nThe medical device sector is one of the fastest-growing segments in Vietnam\u2019s healthcare market. However, it is also highly sensitive from a compliance perspective.
\nThe development and enforcement of a robust industry Code of Conduct is therefore essential.
\nSuch a framework should emphasize:
\n1.\tStrict compliance with Vietnamese laws and international standards,
\n2.\tPatient safety and public health as the primary priority,
\n3.\tTransparency in interactions between industry and healthcare professionals,
\n4.\tPromotion of scientific exchange and education.
\nFor multinational companies, compliance is not optional\u2014it is a strategic differentiator.
\nOperating in Vietnam requires navigating:
\n\u2022\tanti-corruption rules,
\n\u2022\tprocurement regulations,
\n\u2022\tand evolving compliance expectations.
\nCompanies that invest early in ethical business practices and governance structures will benefit from:
\n\u2022\tstronger relationships with regulators,
\n\u2022\tenhanced brand reputation,
\n\u2022\tand long-term market sustainability.
\nE. Trade Agreements as Catalysts: CPTPP, EVFTA, and EVIPA
\nVietnam\u2019s participation in major trade agreements has fundamentally reshaped the investment landscape in healthcare and medical devices.
\n1. CPTPP
\nThe Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP):
\n\u2022\teliminates nearly all tariffs among member states,
\n\u2022\tfacilitates cross-border supply chains,
\n\u2022\tand enhances regulatory transparency.
\nFor the healthcare sector, this translates into:
\n\u2022\treduced import costs for medical equipment,
\n\u2022\timproved access to advanced technologies,
\n\u2022\tand stronger integration into global value chains.
\nThe agreement\u2019s Technical Barriers to Trade (TBT) provisions further promote:
\n\u2022\tclarity in product classification,
\n\u2022\ttransparency in approval processes,
\n\u2022\tand predictability for market entry.
\n2. EVFTA
\nThe EU-Vietnam Free Trade Agreement (EVFTA) is particularly impactful for pharmaceuticals and medical devices:<\/p>\n
\u2022\tUp to 99% of tariffs are eliminated over time,
\n\u2022\tImmediate or phased tariff reductions significantly lower costs,
\n\u2022\tRegulatory cooperation facilitates faster access to innovative treatments.
\nThe EVFTA also strengthens:
\n\u2022\tlabor standards,
\n\u2022\ttransparency obligations,
\n\u2022\tand regulatory convergence.
\n3. Government Procurement and Market Access
\nBoth CPTPP and EVFTA include Government Procurement chapters, which are highly relevant for healthcare:
\nVietnam commits to:
\n\u2022\tnon-discriminatory treatment of foreign bidders,
\n\u2022\ttransparent tender processes,
\n\u2022\tfair evaluation criteria,
\n\u2022\tand effective dispute resolution mechanisms.
\nThe rollout of e-procurement platforms is already improving accessibility and reducing administrative barriers.
\n4. EVIPA \u2013 Investment Protection
\nThe EU-Vietnam Investment Protection Agreement (EVIPA), once fully ratified, will provide:
\n\u2022\trobust investor protection mechanisms,
\n\u2022\taccess to international arbitration,
\n\u2022\tenforceability of awards under established conventions.
\nThis represents a major step toward legal certainty and risk mitigation for foreign investors.
\nF. Latest Developments and Market Activity
\nVietnam\u2019s healthcare sector is increasingly characterized by high-value M&A activity and strategic partnerships.
\nA landmark transaction was:
\n\u2022\tThomson Medical Group\u2019s acquisition of FV Hospital (2024) for USD 381.4 million,
\nmarking one of the largest healthcare deals in Southeast Asia in recent years.
\nThis deal reflects a broader trend:
\nVietnam is evolving from a \u201cfrontier market\u201d to a regional healthcare investment hub.
\nOther notable transactions include:
\n\u2022\tstrategic partnerships (e.g., Raffles Medical),
\n\u2022\tpharmaceutical acquisitions (e.g., Dongwha Pharm, ASKA, Adamed),
\n\u2022\tprivate equity investments (e.g., KKR, CVC Capital).
\nG. Market Entry Options and Investment Conditions
\nForeign investors can enter Vietnam\u2019s healthcare sector through:
\n\u2022\t100% foreign-owned entities,
\n\u2022\tjoint ventures,
\n\u2022\tbusiness cooperation contracts (BCCs).
\nIndicative minimum investment capital:
\n\u2022\tHospitals: USD 20 million
\n\u2022\tPolyclinics: USD 2 million
\n\u2022\tSpecialized clinics: USD 200,000
\nThese thresholds demonstrate Vietnam\u2019s openness while ensuring quality and sustainability of healthcare services.
\nH. Conclusion: A Market of Opportunity\u2014With the Right Approach
\nVietnam\u2019s healthcare sector stands at a decisive inflection point.
\nThe fundamentals are compelling:
\n\u2022\tstrong demand growth,
\n\u2022\tsupportive policy environment,
\n\u2022\tincreasing international integration.
\nAt the same time, success in Vietnam requires more than capital:
\n\u2022\tregulatory understanding,
\n\u2022\tlocal partnerships,
\n\u2022\tand long-term commitment are essential.
\nInvestors who combine commercial ambition with compliance, innovation, and patience will find Vietnam to be one of the most rewarding healthcare markets in Asia.
\n***
\nFor more information on the above, please do not hesitate to contact the author Dr. Oliver Massmann under omassmann@duanemorris.com. Dr. Oliver Massmann is the General Director of Duane Morris Vietnam LLC.<\/p>\n","protected":false},"excerpt":{"rendered":"
A. Overview of Vietnam\u2019s Healthcare Sector Vietnam has firmly established itself as one of the most attractive investment destinations in Southeast Asia. Nowhere is this more evident than in the healthcare and life sciences sector, which is undergoing a structural transformation driven by demographics, economic growth, and policy reform. A rapidly aging population, a growing … <\/p>\n
Continue reading “Lawyer in VIETNAM Dr. Oliver Massmann – INVESTMENT IN THE HEALTHCARE AND MEDICAL DEVICE SECTORS”<\/span><\/a><\/p>\n","protected":false},"author":24,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[2],"tags":[],"ppma_author":[1007],"class_list":["post-1916","post","type-post","status-publish","format-standard","hentry","category-vietnam-general"],"authors":[{"term_id":1007,"user_id":24,"is_guest":0,"slug":"omassmann","display_name":"Dr. Oliver Massmann","avatar_url":"https:\/\/blogs.duanemorris.com\/vietnam\/wp-content\/uploads\/sites\/19\/2014\/08\/massmannoliver-125x150.jpg","author_category":"1","last_name":"Massmann","first_name":"Dr. Oliver","job_title":"","user_url":"http:\/\/www.duanemorris.com\/attorneys\/olivermassmann.html","description":"Read Oliver's bio.<\/a>"}],"_links":{"self":[{"href":"https:\/\/blogs.duanemorris.com\/vietnam\/wp-json\/wp\/v2\/posts\/1916","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.duanemorris.com\/vietnam\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.duanemorris.com\/vietnam\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/vietnam\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/vietnam\/wp-json\/wp\/v2\/comments?post=1916"}],"version-history":[{"count":0,"href":"https:\/\/blogs.duanemorris.com\/vietnam\/wp-json\/wp\/v2\/posts\/1916\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.duanemorris.com\/vietnam\/wp-json\/wp\/v2\/media?parent=1916"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/vietnam\/wp-json\/wp\/v2\/categories?post=1916"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/vietnam\/wp-json\/wp\/v2\/tags?post=1916"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/blogs.duanemorris.com\/vietnam\/wp-json\/wp\/v2\/ppma_author?post=1916"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}